Francisco Javier Melgosa Ramos

Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

JJ Pereyra-Rodriguez, P Herranz, Ignasi Figueras‐Nart et al. · Journal of Investigational Allergology and Clinical Immunology · 2022 · 23 citations · Full text

Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series

Nidia Planella‐Fontanillas, Xavier Bosch‐Amate, Alicia Jiménez Antón et al. · British Journal of Dermatology · 2024 · 23 citations · Full text

Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results

J Rodríguez, Pedro Herranz, Ignasi Figuras-Nart et al. · Dermatitis · 2022 · 16 citations

Upadacitinib effectiveness in moderate‐to‐severe atopic dermatitis: A real‐life multicentre and retrospective study

Francisco Javier Melgosa Ramos, V.A. González-Delgado, José María Sánchez Motilla et al. · Australasian Journal of Dermatology · 2023 · 13 citations · Full text

Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?

Eva María Sánchez‐Martínez, Francisco Javier Melgosa Ramos, Lya Magdalena Moneva‐Léniz et al. · International Journal of Dermatology · 2020 · 11 citations